Praxis Precision Medicines (PRAX) Tops Q1 EPS by 40c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q1 EPS of ($3.20), $0.40 better than the analyst estimate of ($3.60).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• XORTX to voluntarily delist from TSX Venture Exchange
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters